Sara Gibbons
- Virology top 1%
- HIV Research and Treatment 8
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment 23
- HIV/AIDS Research and Interventions 11
- Emergency Medicine top 2%
- HIV-related health complications and treatments 6
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments 4
- Family Practice top 5%
-
- Pharmacological Effects and Toxicity Studies 11
-
- Pneumocystis jirovecii pneumonia detection and treatment 5
-
- Pharmacogenetics and Drug Metabolism 5
Sara Gibbons
34 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Virology 589
- Infectious Diseases 1.3k
- Emergency Medicine 368
- Transplantation 71
- Family Practice 54
Countries citing papers authored by Sara Gibbons
This map shows the geographic impact of Sara Gibbons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Gibbons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Gibbons more than expected).
Fields of papers citing papers by Sara Gibbons
This network shows the impact of papers produced by Sara Gibbons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Gibbons. The network helps show where Sara Gibbons may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sara Gibbons, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 12 | |
| 3 | 2022 | 5 | |
| 4 | 2021 | 71 | |
| 5 | 2021 | 1 | |
| 6 | 2020 | 39 | |
| 7 | 2016 | 94 | |
| 8 | 2010 | 70 | |
| 9 | 2010 | 138 | |
| 10 | 2010 | 31 | |
| 11 | 2008 | 60 | |
| 12 | 2006 | 45 | |
| 13 | 2006 | 64 | |
| 14 | 2003 | 37 | |
| 15 | 2001 | 17 | |
| 16 | 1999 | 224 | |
| 17 | Saquinavir interaction with midazolam: pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease. | 1997 | 25 |
| 18 | 1997 | 216 | |
| 19 | 1990 | 12 | |
| 20 | Comparison and correlation of assays for monitoring cyclosporine drug levels in renal transplant recipients. | 1988 | 5 |
About Sara Gibbons
Sara Gibbons is a scholar working on Virology, Transplantation and Infectious Diseases, having authored 34 papers that have together received 1.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (23 papers), HIV/AIDS Research and Interventions (11 papers), Pharmacological Effects and Toxicity Studies (11 papers), HIV Research and Treatment (8 papers), HIV-related health complications and treatments (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Renal Transplantation Outcomes and Treatments (4 papers). The work is most often cited by research in Virology (589 citations), Infectious Diseases (1.3k citations) and Emergency Medicine (368 citations). Sara Gibbons has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include David Back, Saye Khoo, Michael Barry, Fiona Mulcahy, Catia Marzolini, Concepta Merry, Fiona Marra, Alison Boyle, David M. Burger and Andrew Owen. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.